Skystar Bio-Pharma (SKBI) Reports Q2 EPS of $0.37
Tweet
Share
E-mailGet Alerts SKBI Hot Sheet
Price: $0.00 --0%
Financial Fact:
Diluted (in dollars per share): 0.57
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Diluted (in dollars per share): 0.57
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Skystar Bio-Pharma (NASDAQ: SKBI) reported Q2 EPS of $0.37, versus $0.49 reported last year. Revenue for the quarter came in at $14.2 million, versus $11.3 million reported last year.
For earnings history and earnings-related data on Skystar Bio-Pharma (SKBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
